(CIDRAP News) – A recent survey of nursing homes in two states found that fewer than half had a plan for coping with pandemic influenza, according to a report in this week's Journal of the American Medical Association.
(CIDRAP News) Federal health officials today released their official guidance on allocating vaccine during an influenza pandemic, with few changes from a previous draft that put military personnel, critical health and emergency workers, pregnant women, and small children at the head of the line.
(CIDRAP News) A study from Indiana reveals a long list of problems hampering county-level planning for pandemic influenza, ranging from misunderstanding of the threat and lack of coordination and resources to rivalry between hospital systems.
Editor's Note: CIDRAP's Public Health Practices online database showcases expert-reviewed practices, including useful tools to help others. This article is one of a series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning and response.
(CIDRAP News) With an endorsement from US health officials, Roche, maker of the antiviral drug oseltamivir (Tamiflu), today unveiled a program to encourage more businesses to stockpile the drug to protect employees in case of an influenza pandemic.
(CIDRAP News) The world is far from being well prepared for an influenza pandemic, leading national and international health officials warned at a meeting in Malaysia last week.
As the H5N1 avian influenza virus continues to thrive in birds, there is no vaccine that can provide sure protection if it evolves into a pandemic strain, and governments are paying less attention to the threat, officials said.
(CIDRAP News) David Nabarro, influenza coordinator for the United Nations (UN), said during a press conference yesterday that the world is better prepared to respond to an influenza pandemic, but he added that continuing outbreaks in some countries are a reminder that a major threat remains.
(CIDRAP News) Australian authorities have approved an H5N1 avian influenza vaccine made by the Australian-based pharmaceutical company CSL Limited, giving the country a home-grown defensive tool if the virus evolves into a pandemic strain.
(CDIRAP News) – The Centers for Disease Control and Prevention (CDC) has awarded two contracts worth a total of $12.9 million to develop influenza tests, with the aim of making it possible to distinguish seasonal from avian flu viruses within 3 hours.
(CIDRAP News) Sanofi Pasteur pledged today to give 60 million doses of H5N1 influenza vaccine over 3 years to the World Health Organization (WHO) for a planned stockpile to help poor countries in the event of an influenza pandemic.
